For a person weighing 250 pounds, that represents roughly 52 pounds of weight loss
If it lingers past that window, tell your provider, and a timing or dose adjustment often resolves it
Tirzepatide is a dual agonist it hits both GLP-1 and GIP receptors
Prieto Castro RM, Leva Vallejo ME, Regueiro Lopez JC, Anglada Curado FJ, Alvarez Kindelan J, Requena Tapia MJ
Hard stools caused by constipation are the most common cause of these painful tears
Contextual Cardiovascular Outcomes Trials (CVOTs) Currently, there are no completed head-to-head cardiovascular outcomes trials directly comparing tirzepatide and semaglutide